Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression

Pei-Jou Chua,Suet-Hui Ow,Cheng-Teng Ng,Wan-Hong Huang,Jie-Ting Low,Puay Hoon Tan,Michael W.Y. Chan,Boon-Huat Bay

DOI: https://doi.org/10.1186/s12935-024-03248-x

IF: 6.429

2024-02-07

Cancer Cell International

Abstract:Peroxiredoxin 3 (PRDX3), a mitochondrial hydrogen peroxide scavenger, is known to be upregulated during tumorigenesis and cancer progression. In this study, we provide evidence for the first time that PRDX3 could regulate cellular signaling pathways associated with Matrix Metalloproteinase-1 (MMP-1) expression and activity in breast cancer progression. We show that shRNA-mediated gene silencing of PRDX3 inhibits cell migration and invasion in two triple-negative breast cancer cell lines. Reciprocal experiments show that PRDX3 overexpression promotes invasion and migration of the cancer cells, processes which are important in the metastatic cascade. Notably, this phenomenon may be attributed to the activation of MMP-1, which is observed to be upregulated by PRDX3 in the breast cancer cells. Moreover, immunohistochemical staining of breast cancer tissues revealed a positive correlation between PRDX3 and MMP-1 expression in both epithelial and stromal parts of the tissues. Further pathway reporter array and luciferase assay demonstrated that activation of ERK signaling is responsible for the transcriptional activation of MMP-1 in PRDX3-overexpressed cells. These findings suggest that PRDX3 could mediate cancer spread via ERK-mediated activation of MMP-1. Targeted inhibition of ERK signaling may be able to inhibit tumor metastasis in triple-negative breast cancer.

oncology

What problem does this paper attempt to address?

This paper aims to explore the mechanism of Peroxisome Redoxin 3 (PRDX3) in the progression of breast cancer. Specifically, the study found that PRDX3 can promote the migration and invasion abilities of triple-negative breast cancer cells by regulating the ERK signaling pathway to activate Matrix Metalloproteinase-1 (MMP-1). Additionally, the research shows that PRDX3 is positively correlated with MMP-1 in breast cancer tissues, and inhibiting the ERK signaling pathway may help prevent the metastasis of breast cancer cells that overexpress PRDX3. This finding provides a theoretical basis for developing new therapeutic strategies for triple-negative breast cancer.